Simplified Generation of High-Titer Retrovirus Producer Cells for Clinically Relevant Retroviral Vectors by Reversible Inclusion of a lox-P-Flanked Marker Gene
Open Access
- 31 May 2004
- journal article
- review article
- Published by Elsevier BV in Molecular Therapy
- Vol. 9 (5), 738-746
- https://doi.org/10.1016/j.ymthe.2004.02.010
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Real-Time Quantitative Reverse Transcriptase-Polymerase Chain Reaction as a Method for Determining Lentiviral Vector Titers and Measuring Transgene ExpressionHuman Gene Therapy, 2003
- A novel ‘sort-suicide’ fusion gene vector for T cell manipulationGene Therapy, 2002
- Murine Leukemia Induced by Retroviral Gene MarkingScience, 2002
- CD34 Splice Variant: An Attractive Marker for Selection of Gene-Modified CellsMolecular Therapy, 2000
- Herpes Simplex Virus Thymidine Kinase Gene Transfer for Controlled Graft-versus-Host Disease and Graft-versus-Leukemia: Clinical Follow-up and Improved New VectorsHuman Gene Therapy, 1998
- Correction of Respiratory Burst Activity in X-Linked Chronic Granulomatous Cells to Therapeutically Relevant Levels after Gene Transfer into Bone Marrow CD34+CellsHuman Gene Therapy, 1998
- Green Fluorescent Protein Retroviral Vectors: Low Titer and High Recombination Frequency Suggest a Selective DisadvantageHuman Gene Therapy, 1997
- Polioviruses containing picornavirus type 1 and/ortype 2 internal ribosomal entry site elements: genetic hybrids and theexpression of a foreign gene.Proceedings of the National Academy of Sciences of the United States of America, 1994
- Foot-and-mouth disease virus 2A oligopeptide mediated cleavage of an artificial polyprotein.The EMBO Journal, 1994
- Production of high-titer helper-free retroviruses by transient transfection.Proceedings of the National Academy of Sciences of the United States of America, 1993